chr20-46174905-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021248.3(CDH22):āc.2088G>Cā(p.Glu696Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000921 in 1,411,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021248.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDH22 | NM_021248.3 | c.2088G>C | p.Glu696Asp | missense_variant | 12/12 | ENST00000537909.4 | |
CDH22 | XM_011528994.3 | c.2088G>C | p.Glu696Asp | missense_variant | 12/12 | ||
CDH22 | XM_047440373.1 | c.1848G>C | p.Glu616Asp | missense_variant | 10/10 | ||
CDH22 | XM_024451966.2 | c.1725G>C | p.Glu575Asp | missense_variant | 12/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDH22 | ENST00000537909.4 | c.2088G>C | p.Glu696Asp | missense_variant | 12/12 | 2 | NM_021248.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000404 AC: 6AN: 148454Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000284 AC: 5AN: 175976Hom.: 0 AF XY: 0.0000201 AC XY: 2AN XY: 99568
GnomAD4 exome AF: 0.00000554 AC: 7AN: 1263102Hom.: 0 Cov.: 36 AF XY: 0.00000319 AC XY: 2AN XY: 626378
GnomAD4 genome AF: 0.0000404 AC: 6AN: 148454Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 1AN XY: 72382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | The c.2088G>C (p.E696D) alteration is located in exon 11 (coding exon 11) of the CDH22 gene. This alteration results from a G to C substitution at nucleotide position 2088, causing the glutamic acid (E) at amino acid position 696 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at